New 3-D Vessel OCT Reconstruction Technology Aids Stent Placement

Ilumien Optis System from St. Jude Medical provides a real-time panoramic view of the arteries

 

October 22, 2013
OCT st. jude imaging systems cath lab advanced visualization ilumiens

St. Jude Medical Inc.'s U.S. Food and Drug Administration (FDA)-approved Ilumien Optis PCI optimization system is a new technology designed to provide physicians with a comprehensive disease assessment tool for treating patients with coronary artery disease (CAD).

The Ilumien platform helps physicians better understand which arteries should be treated and how best to treat them. It works by integrating both fractional flow reserve (FFR) technology to measure blood flow blockage inside the coronary arteries and intravascular optical coherence tomography (OCT) imaging technology. There are currently more than 1,200 published articles with clinical evidence supporting St. Jude Medical’s FFR and OCT technologies.

The system is the next generation of the Ilumien System and has several first-of-its-kind enhancements, including automated measurements and stent planning software tools. The OCT imaging technology provides a real-time, 3-D reconstruction of the patient’s vessel, making it easier for physicians to visualize the area they are treating. The new system offers twice the resolution of the earlier generation, which allows for better microscopic examination of disease inside the artery to assist with stent placement. St. Jude Medical is the only company to have these tools available in an integrated platform.

The OCT technology in the new Ilumien Optis system uses the Dragonfly Duo imaging catheter to capture near-infrared light images and measures important vessel characteristics otherwise invisible or difficult to assess with older imaging technology. The catheter offers faster, longer pullbacks that allow the physician to assess more of the patient’s artery in less time.

The wireless PressureWire Aeris technology that is integrated into the platform measures pressure differences in blood flow within the coronary arteries leading to the heart and determines the severity of any narrowings or blockages. Knowing which specific blockages are causing the patient’s blood flow to be ineffective helps guide the interventional cardiologist to determine which lesions warrant stenting, resulting in improved patient outcomes and reduced healthcare costs.

The FFR and OCT measurements captured by the Ilumien Optis system allow physicians to more easily differentiate different types of plaque build-up and determine if the narrowed arteries are causing ischemia, ultimately assisting in stent placement. The automated stent planning tools provide immediate information for assessment and real-time analysis, which may streamline workflow and help physicians diagnose their patients more quickly.

For more information: www.sjm.com

  • An OCT 3-D reconstructed image of a coronary vessel cutaway showing a stent and bifurcating vessels.
The content of this field is kept private and will not be shown publicly.
Type the characters you see in this picture. (verify using audio)
Type the characters you see in the picture above; if you can't read them, submit the form and a new image will be generated. Not case sensitive.